Available now at MDLinx Gastroenterology: Ranked summaries of the most clinically-relevant GI literature refreshed every 24 hours, as well as MDLinx Gastroenterology exclusive content
Your Unread Messages in Gastroenterology
See All >> Messages include industry-sponsored communications and special communications from MDLinx
D Scott Cunningham MD, PhD
Site Editor, MDLinx
Liver stiffness associated with long-term response in HCV
Jill Baker
MDLinx Career Center
NPs and PAs play crucial role amid PCP shortage
Smartest Doc Challenge
MDLinx
GI Oncology Clinical Pearls
MDLinx Reminder
MDLinx
Conference Center Upgraded with New Tools
MDLinx Top Read
MDLinx
Running from that pile of unread journals?
361 Bispectral index-guided induction of general anaesthesia in patients undergoing major abdominal surgery using propofol or etomidate: a double-blind, randomized, clinical trial British Journal of Anesthesia, February 28, 2013 Clinical Article
362 Primary sclerosing cholangitis: a review and update on therapeutic developments Expert Review of Gastroenterology & Hepatology, February 28, 2013 Review Article Clinical Article
363 Comparison Between Botulinum Injection and Removable Covered Self-Expanding Metal Stents for the Treatment of Achalasia Digestive Diseases and Sciences, February 28, 2013 Clinical Article
364 Efficacy of Cholestyramine Ointment in Reduction of Postoperative Pain and Pain during Defecation after Open Hemorrhoidectomy: Results of a Prospective, Single-center, Randomized, Double-blind, Placebo-controlled Trial World Journal of Surgery, February 27, 2013 Clinical Article
365 Diabetic gastroparesis: recent insights into pathophysiology and implications for management Expert Review of Gastroenterology & Hepatology, February 27, 2013 Clinical Article
366 IL28B polymorphisms predict the virological response to standard therapy in patients with chronic hepatitis C virus genotype 4 infection Hepatology International, February 27, 2013 Clinical Article
367 Defensive medicine practices among gastroenterologists in Lombardy: Between lawsuits and the economic crisis Digestive and Liver Diseases, February 27, 2013 Clinical Article
368 FDA approves first drug in over a decade for prevention of organ rejection Full Text Drug Topics, February 27, 2013 Clinical Article
369 Oleanolic acid and ursolic acid: novel Hepatitis C virus antivirals that inhibit NS5B activity Antiviral Research , February 26, 2013 Clinical Article
370 Bevacizumab as Rescue Treatment for Severe Recurrent Gastrointestinal Bleeding in Hereditary Hemorrhagic Telangiectasia Journal of Clinical Gastroenterology, February 26, 2013 Clinical Article
371 Nonbismuth Quadruple “Concomitant” Therapy Versus Standard Triple Therapy, Both of the Duration of 10 Days, for First-Line H. Pylori Eradication: A Randomized Trial Journal of Clinical Gastroenterology, February 25, 2013 Clinical Article
372 Intensified Peginterferon α-2a Dosing Increases Sustained Virologic Response Rates in Heavy, High Viral Load Hepatitis C Genotype 1 Patients With High Low-density Lipoprotein Journal of Clinical Gastroenterology, February 25, 2013 Clinical Article
373 Randomised clinical trial: vancomycin or metronidazole in patients with primary sclerosing cholangitis - a pilot study Alimentary Pharmacology and Therapeutics, February 25, 2013 Clinical Article
374 Comparison of modified percutaneous transhepatic variceal embolization and endoscopic cyanoacrylate injection for gastric variceal rebleeding Full Text World Journal of Gastroenterology, February 25, 2013 Clinical Article
375 Rifaximin in the Treatment of Irritable Bowel Syndrome: Is There a High Risk for Development of Antimicrobial Resistance Journal of Clinical Gastroenterology, February 22, 2013 Clinical Article
376 The use of abdominal muscle training, breathing exercises and abdominal massage to treat pediatric chronic functional constipation Colorectal Disease, February 22, 2013 Clinical Article
377 Pharmacokinetics of cisplatin during hyperthermic intraperitoneal treatment of peritoneal carcinomatosis European Journal of Clinical Pharmacology, February 22, 2013 Clinical Article
378 Effect of ribavirin on viral kinetics and liver gene expression in chronic hepatitis C Gut, February 22, 2013 Review Article
379 Can mosapride citrate reduce the volume of lavage solution for colonoscopy preparation Full Text World Journal of Gastroenterology, February 22, 2013 Clinical Article
380 Quadruple therapy for eradication of Helicobacter pylori Full Text World Journal of Gastroenterology, February 21, 2013 Clinical Article
As published in the NEJM, researchers in the COLONPREV study (Spain) have reported that fecal immunochemical testing (FIT) is as effective as colonoscopy in the detection of colorectal cancer (CRC). The study population was 50-69 years of age and comprised of 26,703 subjects who underwent a one-time colonoscopy and 26,599 subjects who underwent FIT every 2 years. The primary outcome measure was CRC deaths at 10 years. Participation in screening was greater in the FIT group than the colonoscopy group (34.2% vs. 24.6%). Detection of CRC was similar between the two groups (0.1%). Advanced and non-advanced adenomas were detected more frequently in the colonoscopy group than the FIT group (1.9% vs. 0.9% [OR=2.3] and 4.2% vs. 0.4% [OR=9.8], respectively).
Read the article summaryBased on a meta-analysis involving 30 observational studies and 202,965 patients, proton pump inhibitor therapy has been shown to significantly increase the risk of infection with Clostridium difficile (OR = 2.15).
Read the article summaryIn a single institution study involving 424 patients with DM and CRC, those patients treated with metformin had a 30% improvement in OS compared with patients not treated with metformin. Specifically, the metformin-treated patients had a mean survival of 76.9 months compared to 56.9 months.
Read the article summaryIndexed Journals in Gastroenterology: Gastroenterology, American Journal of Gastroenterology, Gut more
Register now to view all the MDLinx contents (FREE)!
Login
Stay current - Media Tool
♦ Subscribe to our free RSS feeds:
Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More ♦
♦ Follow Us on Twitter
Twitter is a rich source of instantly updated information. Join today and follow @MDLinx to start receiving tweets. Learn More ♦
Close